NCT04252404 (FZR) is a clinical trial in Acute Heart Failure, sponsored by Arcothova.

Who is sponsoring NCT04252404?

NCT04252404 is sponsored by Arcothova.

What condition does NCT04252404 study?

NCT04252404 studies Acute Heart Failure.

Is NCT04252404 still recruiting?

NCT04252404 is currently completed. Last updated 21 July 2021.

Last reviewed 2021-07-21 · How we verify

NCT04252404: FZR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FranceLEVO - Zimino Registry (FZR)

Completed Last updated 21 July 2021

What this trial tests

trial in Acute Heart Failure in 600 participants. Completed in 6 May 2021.

Timeline

3 February 2020

Primary endpoint
27 January 2021

6 May 2021

Quick facts

Lead sponsor	Arcothova
Status	Completed
Study type	OBSERVATIONAL
Enrollment	600
Start date	3 February 2020
Primary completion	27 January 2021
Estimated completion	6 May 2021
Sites	1 location across France

Conditions studied

Acute Heart Failure — all drugs for Acute Heart Failure →

Sponsor

Arcothova

Who can join

Eligibility, any sex, with Acute Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The French National Authority for Health (Haute Autorité de santé) requested a registry study to obtain post-market surveillance data to describe baseline clinical profiles, management and outcome of patients treated with Zimino®. This study is designed to provide real-life data on the use, safety and clinical outcomes of Zimino® in routine clinical practice in France.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Overview of the current use of levosimendan in France: a prospective observational cohort study.
Cholley B, Bojan M, Guillon B, Besnier E, et al · · 2023 · cited 11× · PMID 37552372 · DOI 10.1186/s13613-023-01164-3

Verify or expand the search:

Other recruiting trials for Acute Heart Failure

Currently open trials in the same condition.

NCT06587854 — a PRagmatic Observational Study of Congestion proFILes in patiEnts With Acute Heart Failure · recruiting
NCT07008365 — The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure · Phase 3 · recruiting
NCT06465498 — Investigating aCute heArt failuRe Decongestion Guided by Lung UltraSonography · NA · recruiting
NCT06597331 — Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital · recruiting
NCT06166654 — Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04252404 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Arcothova
Last refreshed: 21 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04252404.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing